Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Choice of Anticoagulant for Primary Hemostasis Studies With PFA200® (Platelet Function Analyser)

NCT06753838 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.

NCT NCT06753838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06753838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Choice of Anticoagulant for Primary Hemostasis Studies With PFA200® (Platelet Function Analyser)
Lead sponsor
Centre Hospitalier Universitaire Dijon
Phase
Observational
Overall status
Recruiting
Start date
January 21, 2025
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemostasis